Ask the Experts: Beyond the Basics in Managing Insulin and Other Antihyperglycemic Therapies for Type 2 Diabetes
After registration you will receive an email confirmation with instructions for joining the webinar.
The handout will be available at least 24 hours prior to the webinar.
Activity Type: Application-based
CE Credits: 1 hour (0.1 CEU), no partial credit
Activity Fee: Free of charge
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Target Audience
This continuing pharmacy education activity was planned to meet the needs of pharmacists with an interest in diabetes management and new drug therapies who practice in hospitals, ambulatory care clinics, specialty pharmacies, and community pharmacies.
Activity Content
In this activity, the faculty will use clinical case vignettes to address advanced challenges related to the use of insulin and other antihyperglycemic agents in the management of type 2 diabetes, such as the influence of comorbidities. The content for this activity is based on questions and comments from participants at a recent educational symposium on this topic.
Learning Objectives
At the conclusion of this application-based educational activity, participants should be able to- Summarize key challenges related to the use of insulin and other antihyperglycemic agents in patients with type 2 diabetes with a high burden of comorbidities.
- Apply strategies to improve glycemic management in patients with type 2 diabetes.
Faculty
Curtis L. Triplitt, Pharm.D., CDCES, FADCES Initiative Chair
Clinical Associate Professor, Medicine/Diabetes
University of Texas Health Science Center at San Antonio
Associate Director, Diabetes Research
Texas Diabetes Institute, University Health System
San Antonio, Texas
Curtis L. Triplitt, Pharm.D., CDCES, FADCES, is Clinical Associate Professor of Medicine, Division of Diabetes and Clinical Assistant Professor of Pharmacy at the University of Texas Health Science Center at San Antonio. Dr. Triplitt practices at the Texas Diabetes Institute, where he manages patients with an endocrinologist and is involved with diabetes and metabolism research.
Dr. Triplitt received his Doctor of Pharmacy degree from the University of Texas Health Science Center at San Antonio and the University of Texas at Austin. He completed an ASHP-accredited primary-care residency at the William S. Middleton Memorial Veterans Hospital in Madison, Wisconsin.
Dr. Triplitt is the Editor-in-Chief of Diabetes Spectrum and past Vice-Chair of the Texas Diabetes Council, Texas Department of State Health Services. He has served as an investigator on multiple clinical trials focusing on type 2 diabetes, including the effects of medications on insulin sensitivity, glycemic control, and hypertension, and he has published over 50 peer-reviewed articles and 10 book chapters on diabetes. In 2008 he was honored as Pharmacy Preceptor of the Year for the University of Texas. Dr. Triplitt lectures at both the national and statewide levels concerning diabetes and has been involved with the development of multiple clinical treatment algorithms for the prevention and treatment of diabetes in the State of Texas.
Joshua J. Neumiller, Pharm.D., CDE, FASCP
Vice Chair and Associate Professor
Department of Pharmacotherapy
Washington State University College of Pharmacy
Spokane, Washington
Joshua J. Neumiller, Pharm.D., CDE, FASCP, is Vice Chair and Associate Professor in the Department of Pharmacotherapy at Washington State University College of Pharmacy in Spokane, Washington.
Dr. Neumiller earned a Bachelor of Science degree in general science and a Doctor of Pharmacy degree from Washington State University in Spokane, Washington. He is a certified diabetes educator (CDE) and a fellow of the American Society of Consultant Pharmacists (ASCP).
Dr. Neumiller’s research interests involve the management of diabetes and prevention of adverse drug events during transitions in care. He is Editor-in-Chief for Diabetes Spectrum, a journal of the American Diabetes Association (ADA). He also is a contributing author for the ADA books, Medications for the Treatment of Diabetes, Practical Insulin, and American Diabetes Association Guide to Nutrition Therapy for Diabetes.
Dr. Neumiller is a member of ADA, ASCP, American Association of Diabetes Educators, American Pharmacists Association, and Washington State Pharmacy Association. He was recently awarded the 2016 Albert B. Prescott Pharmacy Leadership Award from the Pharmacy Leadership and Education Institute.
Methods and CE Requirements
This is a live broadcast consisting of audio, presentation slides, and an activity evaluation tool. A live webinar brings the presentation to you. Listen to the speaker present in “real time” as you watch the slides on the screen. You will have the opportunity to ask the speaker questions at the end of the program. Please join the conference at least 5 minutes before the scheduled start time for important announcements.
To receive CE credit, participants must submit an enrollment code (announced during the webinar) and complete the evaluation. Participants will process CE credit online at http://elearning.ashp.org/my-activities. CPE credit will be reported directly to CPE Monitor. Per ACPE, CPE credit must be claimed no later than 60 days from the date of the live activity or completion of a home-study activity.
Viewing Webinar as a Group
To view the webinar as a group, one person serving as the group coordinator should register. A few minutes before the webinar begins, the group coordinator should launch the webinar (using instructions from the email confirmation) and select the option to open audio via VoIP (Voice Over IP) or use a touch tone phone with the dial-in information. Each participant will process their own continuing education online.
Webinar System Requirements
Be sure to view the webinar system requirements for Windows, Mac, iOS, and Android prior to the activity.
